Loading organizations...
Key people at Brain Trust Accelerator Fund II.
Brain Trust Accelerator Fund II was founded in 2013 by John Reher (Founder & Managing Director).
Brain Trust Accelerator Fund II is a venture capital fund focusing on early-stage investments in the brain disease sector. It targets translational stage companies developing diagnostics and treatments for neurological disorders. Building on Fund I's success, the fund supports enterprises addressing unmet medical needs in brain health.
The managing entity, Brain Trust Accelerator Fund, was established in 2006. It was founded to strategically deploy venture capital accelerating the development of solutions for brain-related diseases. This recognized the critical demand for specialized funding and expertise within this complex therapeutic area, a focused approach underpinning its investment strategy.
The fund invests in innovators in brain health, typically within Series A and Seed stages. Its efforts seek to benefit patients globally by advancing therapeutic and diagnostic breakthroughs. The long-term vision involves achieving robust financial returns while fostering positive impact for individuals suffering from brain diseases, enhancing patient outcomes and quality of life.
Brain Trust Accelerator Fund II was founded in 2013 by John Reher (Founder & Managing Director).
Key people at Brain Trust Accelerator Fund II.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 20, 2021 | Chase Therapeutics | $20.0M Series B | Javier Romero | Makana Holdings, Rise of the Rest |
| May 12, 2014 | Chase Pharmaceuticals | $21.0M Series B | Greg Parekh | Vikram Sudarsan |